Analyst Ratings For Globus Medical (NYSE:GMED)

Story continues below

.

Some recent analyst ratings include

  • 2/22/2018-Needham & Company LLC Reiterated Rating of Hold.
  • 2/22/2018-Canaccord Genuity Reiterated Rating of Buy .
  • 1/10/2018-Barclays Reiterated Rating of Sell.
  • 1/10/2018-Wells Fargo & Co Reiterated Rating of Outperform.

Recent Insider Trading Activity For Globus Medical (NYSE:GMED)
Globus Medical (NYSE:GMED) has insider ownership of 28.21% and institutional ownership of 65.72%.

  • On 12/15/2017 Steven Payne, CAO, sold 3,076 with an average share price of $39.30 per share and the total transaction amounting to $120,886.80.
  • On 12/13/2017 Anthony L Williams, President, sold 15,000 with an average share price of $38.30 per share and the total transaction amounting to $574,500.00.
  • On 12/4/2017 David D Davidar, Director, sold 55,383 with an average share price of $40.66 per share and the total transaction amounting to $2,251,872.78.
  • On 11/9/2017 A Brett Murphy, Insider, sold 51,449 with an average share price of $35.00 per share and the total transaction amounting to $1,800,715.00.
  • On 9/6/2017 A Brett Murphy, Insider, sold 15,000 with an average share price of $29.99 per share and the total transaction amounting to $449,850.00.
  • On 6/5/2017 Anthony L Williams, President, sold 16,153 with an average share price of $31.94 per share and the total transaction amounting to $515,926.82.
  • On 8/5/2016 A Brett Murphy, Insider, sold 107,692 with an average share price of $23.37 per share and the total transaction amounting to $2,516,762.04.

Recent Trading Activity for Globus Medical (NYSE:GMED)
Shares of Globus Medical closed the previous trading session at 49.13 up +1.13 2.35% with 50.880001068115234 shares trading hands.

An ad to help with our costs